Sintx Technologies (NASDAQ:SINT) Announces Quarterly Earnings Results

Sintx Technologies (NASDAQ:SINT) announced its earnings results on Thursday. The company reported ($0.24) earnings per share for the quarter, topping the consensus estimate of ($0.31) by $0.07, FiscalAI reports. Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The company had revenue of $2.19 million during the quarter, compared to analyst estimates of $1.33 million.

Here are the key takeaways from Sintx Technologies’ conference call:

• Third-quarter revenue rose 953% year over year to $2.2 million, primarily on aerospace and industrial manufacturing sales, while gross profit reached $1.4 million and gross margin improved to 62%. Revenue was twice the high end of the company’s prior guidance, which it attributed to customer demand and improved manufacturing execution.
• Net loss narrowed 55% to $1.6 million, and operating expenses fell 13% year over year. Management said the lower reported R&D expense largely reflected overhead reallocation rather than a reduction in underlying research activity.
• Liquidity remains a concern: cash was $2 million at quarter-end, and operating cash use totaled $6.6 million in the first nine months. A post-quarter warrant exercise brought in about $2 million, but the company continues to incur losses and is evaluating additional financing.
• SINTX has begun full commercialization of its FDA-cleared SiNAPTIC foot-and-ankle system and reported initial commercial revenue in 2026. It is also advancing silicon-nitride/PEEK 3D-printed implants and textile applications, though further studies and regulatory steps remain before broader commercialization.
• The company could not provide an expectation for delivery of the remaining portion of $3.2 million in purchase orders during the fourth quarter. Management cautioned that quarterly revenue may fluctuate with order timing, production schedules, and shipments.

Sintx Technologies Stock Down 2.4%

NASDAQ:SINT traded down $0.04 on Thursday, reaching $1.62. 64,555 shares of the company’s stock were exchanged, compared to its average volume of 33,820. The business has a fifty day moving average of $1.80 and a 200-day moving average of $2.20. Sintx Technologies has a 52-week low of $1.40 and a 52-week high of $4.46.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Ascendiant Capital Markets increased their price objective on shares of Sintx Technologies from $12.00 to $12.50 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a research report on Thursday, October 15th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.50.

Sintx Technologies Company Profile

SINTX Technologies, Inc (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications.

In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.